STRO
Sutro Biopharma Inc

1,134
Mkt Cap
$117.74M
Volume
98,622.00
52W High
$21.50
52W Low
$5.23
PE Ratio
-0.53
STRO Fundamentals
Price
$13.85
Prev Close
$13.07
Open
$13.01
50D MA
$9.85
Beta
1.50
Avg. Volume
129,482.50
EPS (Annual)
-$29.61
P/B
-1.35
Rev/Employee
$183,559.17
Loading...
Loading...
News
all
press releases
Sutro Biopharma, Inc. (NASDAQ:STRO) Short Interest Down 27.8% in December
Sutro Biopharma, Inc. (NASDAQ:STRO - Get Free Report) was the recipient of a significant decline in short interest in December. As of December 31st, there was short interest totaling 404,777 shares...
MarketBeat·11h ago
News Placeholder
More News
News Placeholder
Sutro Biopharma, Inc. (NASDAQ:STRO) Given Average Recommendation of "Hold" by Analysts
Sutro Biopharma, Inc. (NASDAQ:STRO - Get Free Report) has been given a consensus recommendation of "Hold" by the eight analysts that are presently covering the stock, MarketBeat.com reports. Two...
MarketBeat·16d ago
News Placeholder
FY2025 EPS Estimate for Sutro Biopharma Increased by Analyst
Sutro Biopharma, Inc. (NASDAQ:STRO - Free Report) - Investment analysts at HC Wainwright upped their FY2025 earnings per share (EPS) estimates for Sutro Biopharma in a report issued on Monday...
MarketBeat·23d ago
News Placeholder
Sutro Biopharma, Inc. (NASDAQ:STRO) Short Interest Down 85.9% in December
Sutro Biopharma, Inc. (NASDAQ:STRO - Get Free Report) was the recipient of a significant decline in short interest during the month of December. As of December 15th, there was short interest totaling...
MarketBeat·24d ago
News Placeholder
HC Wainwright Forecasts Strong Price Appreciation for Sutro Biopharma (NASDAQ:STRO) Stock
HC Wainwright increased their target price on shares of Sutro Biopharma from $2.00 to $10.00 and gave the stock a "neutral" rating in a research report on Monday...
MarketBeat·26d ago
News Placeholder
Smart Money Abandons Single-Asset Risk: Why Platforms Now Command 60% of Pharma Pipelines
Smart Money Abandons Single-Asset Risk: Why Platforms Now Command 60% of Pharma Pipelines Smart Money Abandons Single-Asset Risk: Why Platforms Now Command 60% of Pharma Pipelines PR Newswire...
PR Newswire·29d ago
News Placeholder
Velan Capital Investment Management LP Acquires 2,030,000 Shares of Sutro Biopharma, Inc. $STRO
Velan Capital Investment Management LP lifted its stake in Sutro Biopharma, Inc. (NASDAQ:STRO - Free Report) by 197.1% during the second quarter, according to the company in its most recent 13F...
MarketBeat·1mo ago
News Placeholder
Sutro Biopharma, Inc. (NASDAQ:STRO) Receives Average Recommendation of "Hold" from Brokerages
Shares of Sutro Biopharma, Inc. (NASDAQ:STRO - Get Free Report) have received a consensus recommendation of "Hold" from the eight research firms that are currently covering the stock, MarketBeat...
MarketBeat·1mo ago
News Placeholder
Sutro Biopharma (NASDAQ:STRO) Shares Gap Down - What's Next?
Sutro Biopharma (NASDAQ:STRO) Shares Gap Down - Time to Sell...
MarketBeat·1mo ago
News Placeholder
Sutro Biopharma (NASDAQ:STRO) Shares Gap Up - What's Next?
Sutro Biopharma (NASDAQ:STRO) Shares Gap Up - Time to Buy...
MarketBeat·1mo ago
<
1
2
...
>

Latest STRO News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.